Pepto Bismol, widely used in the United States to treat upset stomachs and diarrhea, is not available in Europe due to strict pharmaceutical regulations. The main ingredient, bismuth subsalicylate, is considered a derivative of salicylates, similar to aspirin. European health authorities are cautious about its potential risks, especially concerning children, as salicylates have been linked to Reye’s syndrome—a rare but serious condition. Additionally, differences in regulatory standards for over-the-counter medications further contribute to its unavailability. Instead, Europe offers alternative medications that meet their safety standards for similar symptoms.
